News

Data from an ongoing real-world study show that treatment with Signifor (pasireotide) is able to normalize cortisol levels for sustained periods in patients with Cushing’s disease for whom surgery has failed or is not an option. Half of the new Signifor users reached normal cortisol…

Adrenal gland transplants resulted in complete resolution of Cushing’s disease symptoms after no long-lasting benefits were seen with pituitary surgery, according to a new long-term study in four patients. The procedure also enabled lower doses of hormone replacement therapy, the findings showed. The research, “Autologous Adrenal…

People living with HIV who develop Cushing’s syndrome due to drug interactions tend to have more severe symptoms than non-infected people, a study found. The study, “Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database,”…

Fluconazole — a treatment for fungal infections that can lower cortisol levels — could be a potential therapy for severe Cushing’s syndrome caused by ACTH-secreting tumors located outside the pituitary gland, a case report suggests. According to the report, “Fluconazole treatment in severe…

The administration with food of the Cushing’s syndrome therapy Korlym (mifepristone) will be covered by a new U.S. patent, according to Corcept Therapeutics – the company marketing Korlym. Upon issuance by the U.S. Patent and Trademark Office, Corcept plans to list the patent in the U.S.

Rare diseases deeply affect not only the children who experience them, but also their healthy brothers and sisters, as their parents can attest.    Two entries in November’s “Disorder: The Rare Disease Film Festival” will focus on what siblings go through, according to the San Francisco festival’s co-founder,…

Levels of adrenocorticotropic hormone (ACTH) in circulation after pituitary surgery may help predict which Cushing’s disease patients will achieve early remission and which will eventually see the disease return, a study shows. Also, the earlier that patients reached their lowest peak of ACTH levels, the better their long-term…

Developing gene therapies for rare diseases is one thing. Creating gene-edited “designer babies” is quite another. German legal expert Timo Minssen outlined the potentially explosive ethical landmines surrounding such issues during a recent talk at the New York Genome Center. Minssen directs the Center for Advanced Studies in…

Measures of the degree of fat in bone marrow could be a reliable marker of bone health, helping doctors to predict the risk of fractures in people with Cushing’s syndrome, a study has found. The study, “High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures”…

Pituitary surgery that restores healthy cortisol levels in people with Cushing’s disease only partly reverses changes in the brain that were caused by excessive levels, a study from China reports. Specifically, the surgery partly normalizes gray matter volume, where most nerve and other cells are found, but alterations to the…